Brachytherapy evolution as seen today

Abstract

AbstractWhile brachytherapy is the oldest form of radiation therapy, it is also a very exciting field from both physics and clinical perspectives. From the physics standpoint, brachytherapy dosimetry is largely being governed by the inverse‐square law, leading to an unparalleled dose deposition kernel (dose emitted by a seed or single dwell position), even compared to proton or heavy‐ion beamlets. There is slightly more dose beyond the central deposition point, but comparatively very little prior to it, that is, little or no entrance dose! It is easy to sum multiple dwell positions that cover a tumor, and the intensity can be modulated quite effectively using dwell times. From a clinical perspective, what sets brachytherapy apart from other intraoperative modalities (e.g., laser, radiofrequency, cryogenic) is our ability to precisely calculate the energy deposited across the relevant patient geometry, anticipate the effect from known dose‐outcome relationships, and deliver that energy with exquisite control and selectively to the target volume while sparing organs at risks. This targeting ability has improved substantially over the last two decades. It is built upon key foundational elements, many of which stem from the research and development within our medical physics community. This article provides an overview of these elements that combine to make brachytherapy a successful and developing radiotherapy modality.